4Peaks vs Jalview
Side-by-side comparison for macOS
4Peaks
7.0Visualise and edit DNA sequence trace files
Jalview
8.0Multiple sequence alignment editor, visualiser, analysis and figure generator
| Metric | 4Peaks | Jalview |
|---|---|---|
| Category | Science | Science |
| AI Score | 7.0 | 8.0 |
| 30-day Installs | 1 | 24 |
| 90-day Installs | 10 | 73 |
| 365-day Installs | 41 | 299 |
| Version | 1.8 | 2.11.5.1 |
| Auto-updates | No | No |
| Deprecated | No | No |
| GitHub Stars | — | — |
| GitHub Forks | — | — |
| Open Issues | — | — |
| License | — | — |
| Language | — | — |
| Last GitHub Commit | — | — |
| First Seen | Dec 11, 2014 | Jul 23, 2019 |
Reviews
4Peaks
4Peaks is a specialized tool for visualizing and editing DNA sequence trace files, making it invaluable for researchers in molecular biology and genetics. It offers a user-friendly interface for analyzing complex biological data.
4Peaks visualizes and edits DNA sequence trace files, aiding in the analysis of genetic data.
Pros
- + Specialized tool for bioinformatics, catering to a niche but important audience.
- + Provides detailed visualization and editing of DNA trace files.
- + Integrates well with macOS for a smooth user experience.
Cons
- - No auto-update feature, requiring manual checks for updates.
- - Limited to macOS, which may restrict accessibility for some users.
Jalview
Jalview is a specialized tool for editing, visualizing, and analyzing multiple sequence alignments, ideal for researchers in molecular biology and evolutionary studies. It offers user-friendly features for generating figures and conducting detailed analyses, making it a valuable resource for biologists and bioinformaticians.
Jalview enables users to create, edit, analyze, and visualize multiple sequence alignments, which are crucial for molecular biology research.
Pros
- + Specialized for molecular biology and bioinformatics tasks
- + User-friendly interface for non-experts
- + Strong visualization and figure generation capabilities
Cons
- - No auto-update feature
- - Niche appeal limits its broader adoption